MeSH tree: C12.200.758
Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when treated with an oral combination ...
Mar 2, 2026
0
7
A large, multi-center study published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy regimens used to treat testicular ...
Feb 22, 2026
0
16
Staying fit and active has long been associated with better heart and overall health. It might also improve the chances of survival for people with some forms of cancer. A study published in the journal JAMA Network Open ...
Shocking inequalities experienced by men with learning disabilities when diagnosed with prostate cancer have been highlighted in a study by University of Manchester and Christie NHS Foundation Trust researchers. Published ...
Feb 20, 2026
0
7
A pioneering genetic test is improving early diagnosis and treatment for people with hereditary cancer caused by a genetic condition. The test, developed with the help of Newcastle University scientists, identifies specific ...
Feb 19, 2026
0
12
A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way that can be compared between ...
Feb 9, 2026
0
10
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival ...
Feb 9, 2026
0
21
This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it's putting that claim to the test. After attracting global attention from researchers and billions ...
Feb 7, 2026
0
14
During the early years of the COVID-19 pandemic, experts worried that disruptions to cancer diagnosis and treatment would cost lives. A new study suggests they were right.
Feb 5, 2026
0
8
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the placebo in men receiving ...
Feb 2, 2026
0
9
